|
期刊名称：FORENSIC TOXICOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
The journal Forensic Toxicology provides an international forum for publication of studies on toxic substances, drugs of abuse, doping agents, chemical warfare agents, and their metabolisms and analyses, which are related to laws and ethics. It includes original articles, reviews, mini-reviews, short communications, and case reports. Although a major focus of the journal is on the development or improvement of analytical methods for the above-mentioned chemicals in human matrices, appropriate studies with animal experiments are also published.
Forensic Toxicology is the official publication of the Japanese Association of Forensic Toxicology (JAFT) and is the continuation of the Japanese Journal of Forensic Toxicology (ISSN 0915-9606).
Forensic Toxicology is the official publication of the Japanese Association of Forensic Toxicology (JAFT) and is the continuation of the Japanese Journal of Forensic Toxicology (ISSN 0915-9606). The journal provides an international forum for publication of studies on toxic substances, drugs of abuse, doping agents, chemical warfare agents, and their metabolisms and analyses, which are directly and indirectly related to laws and ethics. It includes original articles, reviews, minireviews, short communications, and case reports. Although a major focus of the journal is on the development or improvement of analytical methods for the above-mentioned chemicals in human matrices, studies with animal experiments are also welcome.
The Japanese Association of Forensic Toxicology (JAFT) was founded in 1982 as the Japanese branch of The International Association of Forensic Toxicologists (TIAFT).
Its objectives are to promote studies on toxicology directly and indirectly related to laws and ethics. JAFT also fosters the exchange of scientific information through meetings and their journal Forensic Toxicology both domestically and internationally.
Instructions to Authors
Instructions for authors
Manuscript submission
A Manuscript should be submitted preferably as a pdf file to the editorial office as an e-mail attachment. If this is not possible, a printout of the manuscript must be submitted in triplicate.
Please be sure to include your e-mail address and your fax number. Please do not transmit electronic data to the publisher until your manuscript has been reviewed and accepted for publication. Please follow the instructions below.
Editorial decisions regarding acceptance, revision, or rejection of a manuscript are based on the reviewers’ reports. Authors should retain backup copies.
Editorial office
Prof. Osamu Suzuki, Chief Editor, Forensic Toxicology
Department of Legal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu 431-3192, Japan, e-mail: suzuko@hama-med.ac.jp
Legal requirements
The author(s) guarantee(s) that the manuscript will not be published elsewhere in any language without the consent of the copyright owners, that the rights of third parties will not be violated, and that the publisher will not be held legally responsible should there be any claims for compensation.
Authors wishing to include figures or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.
The Copyright Transfer Statement should be signed and faxed to the publisher with the corrected proofs.
Manuscripts submitted for publication must contain a statement to the effect that all human studies have been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. It should also be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under study should be omitted. Reports of animal experiments must state that the ”Principles of laboratory animal care” (NIH publication No. 86-23, revised 1985) were followed, as were specific national laws where applicable.
The editors reserve the right to reject manuscripts that do not comply with the above-mentioned requirements. The author will be held responsible for false statements or failure to fulfill the above-mentioned requirements.
Manuscript preparation
Manuscripts must be written in English and typed in double-line spacing with 3-cm margins; pages and lines should be numbered using the automatic numbering function. Authors whose first language is not English are urged to have their manuscript read by a colleague who is a native English speaker and is familiar with their field of work before submitting the paper.
Please arrange your manuscript as follows:
- Title page (including name(s) of author(s), a concise and informative title, affiliation(s) and address(es) of the author(s), e-mail address, telephone and fax numbers of the corresponding author)
- Abstract (less than 250 words for a full paper, and less than 100 words for a case report and a short communication)
- Up to six keywords
- Text of the paper divided into following sections, if appropriate: Introduction; Materials and methods; Results; Discussion; Acknowledgements; References; tables; figure legends
Abbreviations should be defined at first mention in the abstract and again in the main body of the text and used consistently thereafter.
References
The list of references should include only works that are cited in the text and that have been published or accepted for publication. Personal communications should be mentioned only in the text.
References should be numbered in the order in which they appear in the text and should be listed in numerical order. References, with correct punctuation, should be styled as follows:
*Journal papers: name(s) and initial(s) of all authors; year; full title; journal title abbreviated in accordance with international practice; volume number; first and last page numbers
Example:
Hattori H, Arinobu T, Iwai M, Masuda K, Suzuki O, Seno H (2005) Analysis of butyrophenones in whole blood specimens by LC/MS/MS using a new polymer column. Jpn J Forensic Toxicol 23:13–17
If available, the DOI of the cited literature should be added at the end of the reference in question.
Example:
Moriya F, Hashimoto Y (2004) Nicotine and cotinine levels in blood and urine from forensic autopsy cases. Legal Med 6: 164–169. DOI 10.1016/j.legalmed.2004.04.005
A paper published online but not yet in print can be cited using the DOI.
Example:
Hann S, Latkoczy C, Bereuter TL, Prohaska T, Stingeder G, Reiter C (2005) Reconstruction of a case of thallium poisoning using LA-ICP-SFMS. Int J Legal Med DOI 10.1007/s00414-004-0465-0
*Single contributions in a book: name(s) and initial(s) of all authors; year; title of article; editor(s); title of book; edition; volume number; publisher; place of publication; page numbers
Example:
Rifkind BM, Tamir I, Heiss G (1978) Preliminary high_density lipoprotein findings. In: Gotto AM, Miller F, Oliver MF (eds) High_density lipoprotein and atherosclerosis. Elsevier, Amsterdam, pp 109–119
*Book: name and initial(s) of all authors; year; title; publisher; place of publication
Example:
Suzuki O, Watanabe K (2005) Drugs and poisons in humans: a handbook of practical analysis. Springer, Berlin Heidelberg New York
Tables and figures
Tables must be numbered consecutively with arabic numerals. They should have a title explaining any abbreviation used in that table. Footnotes to tables should be indicated by superscript lowercase letters (or asterisks for significance values and other statistical data).
Illustrations must be restricted to the minimum needed to clarify the text. All figures (photographs, graphs, or diagrams) should be cited in the text, and numbered consecutively throughout. Figure parts should be identified by lowercase roman letters (a, b, c, etc.). If illustrations are supplied with uppercase labeling, lowercase letters will still be used in the figure legends and citations. Figure legends must be brief, self-sufficient explanations of the illustrations. The legends should be placed at the end of the text.
Submit all figures as separate files and do not integrate them within the text. The preferred figure formats are EPS for vector graphics exported from a drawing program and TIFF for halftone illustrations. EPS files must always contain a preview in TIFF of the figure. Microsoft PowerPoint files and illustrations embedded in Microsoft Word documents are not acceptable. The file name should include the figure number.
Line drawings. Inscriptions should be legible, with initial capital letters and appropriately scaled to the size of the drawing. Scanned line drawings should be digitized with a resolution of 800 dpi relative to the final figure size.
Halftone illustrations (black and white and color). Magnification should be indicated by scale bars. For scanned halftone illustrations, a resolution of 300 dpi is usually sufficient.
Color illustrations will be accepted. However, authors will be expected to make a contribution toward the extra costs (¥110,000 for the first and ¥60,000 for each additional page).
Save color illustrations as RGB (8 bits per channel) in TIFF format.
Size of figures. The figures, including legends, should match either the column width (84 mm) or the print area of 174 × 234 mm. The publisher reserves the right to reduce or enlarge illustrations.
Manuscripts and the figures will not be returned unless specifically requested by the authors.
Manuscripts in electronic form
After acceptance please send your electronic version of your manuscript to the editorial office in addition to the printout of the whole manuscript. Please follow the Technical Instructions for Manuscripts and Illustrations in Electronic Form published regularly in the journal.
Please save your files in the following formats:
Text: RTF (Rich Text Format) or Microsoft Word-compatible formats
Figures: EPS or TIFF
Electronic Supplementary Material
Electronic Supplementary Material (ESM) for a paper will be published in the electronic edition of the journal provided the material is submitted in electronic form together with the manuscript, accepted after peer review.
ESM may consist of: information that cannot be printed, e.g., animations, video clips, sound recordings (use QuickTime, .avi, .mpeg, animated GIFs, or any other common file format); information that is more convenient in electronic form, e.g., sequences, spectral data, etc.; large quantities of original data that relate to the paper, e.g. additional tables; large numbers of illustrations (color and black & white), etc.
Legends must be brief, self-sufficient explanations of the ESM. ESM is to be numbered and referred to as S1, S2, etc.
After acceptance for publication, ESM will be published as received from the author in the online version only. Reference will be given in the printed version.
Proofreading
Authors are informed by e-mail that a temporary URL has been created from which they can obtain their proofs. Proofreading is the responsibility of the author. Authors should make their proof corrections (formal corrections only) on a printout of the pdf file supplied, checking to see that the text is complete and that all figures and tables are included. Substantial changes in content, e.g., new results, corrected values, and changes in title and authorship, are not allowed without the approval of the responsible editor. In such a case please contact the editorial office before returning the proofs to the publisher. After online publication, corrections can be made only in exceptional cases and in the form of an erratum, which will be hyperlinked to the paper.
Online First
Papers will be published online about one week after receipt of the corrected proofs. Papers published online can already be cited by their DOI. After release of the printed version, the paper can also be cited by issue and page numbers.
Offprints
If you wish to order offprints you must return the order form that is provided with the proofs and return it together with the corrected proofs.
Open Choice Publication
In addition to the normal publication process (whereby an article is submitted to the journal and access to that article is granted to customers who have purchased a subscription), Springer now provides an alternative publishing option: Springer Open Choice. A Springer Open Choice article receives all the benefits of a regular "subscription-based" article, but in addition is made available publicly through Springer's online platform SpringerLink. To publish via Springer Open Choice, upon acceptance please visit www.springer.com/openchoice to complete the relevant order form and provide the required payment information. Payment must be received in full before publication, or articles will be published as regular subscription-model articles. We regret that Springer Open Choice cannot be ordered for published articles
Editorial Board
Chief Editor
Osamu Suzuki
Department of Legal Medicine
Hamamatsu University School of Medicine
1-20-1 Handayama, Hamamatsu 431-3192, Japan
E-mail: suzuko@hama-med.ac.jp
Editorial Board
Hee-Sun Chung
Seoul, Korea
Akira Ishii
Nagoya, Japan
Malgorzata Klys
Kraków, Poland
Keiko Kudo
Fukuoka, Japan
Dominick A. Labianca
New York, USA
Fumio Moriya
Kurashiki, Japan
Harald Schuetz
Giessen, Germany
Hiroshi Seno
Aichi, Japan
Yasuo Seto
Kashiwa, Japan
Shinichi Suzuki
Kashiwa, Japan
Hitoshi Tsuchihashi
Osaka, Japan
Advisory Board
Kimiko Aoki
Tokyo, Japan
Olaf H. Drummer
Southbank, Australia
Kunio Gonmori
Hamamatsu, Japan
Marilyn Huestis
Baltimore, USA
Hiroyuki Inoue
Kashiwa, Japan
Daniel S. Isenschmid
Detroit, USA
Pascal Kintz
Illkirch, France
Mark LeBeau
Quantico, USA
Junting Liu
Shenyang, P. R. China
Ray H. Liu
Kaohsiung, Taiwan
Hans H. Maurer
Homburg, Germany
Yokichi Ohno
Tokyo, Japan
Anya Pierce
Dublin, Ireland
Nariaki Takayama
Kanazawa, Japan
Einosuke Tanaka
Tsukuba, Japan
Masaru Terada
Tokyo, Japan
Noriko Tsunoda
Tokyo, Japan
Anthony T. Tu
Fort Collins, USA
Makoto Ueki
Tokyo, Japan
Alain G. Verstraete
Ghent, Belgium
Kanako Watanabe
Hamamatsu, Japan
Kazuhito Watanabe
Kanazawa, Japan
Hideyuki Yamada
Fukuoka, Japan
Mikio Yashiki
Hiroshima, Japan
Takemi Yoshida
Tokyo, Japan
|
|
|
|
